591 TERUTROBAN, A TXA2/PGH2 RECEPTOR ANTAGONIST, REDUCES PORTAL PRESSURE, AMELIORATES INTRAHEPATIC VASCULAR RESISTANCE AND INCREASES NITRIC OXIDE BIOAVAILABILITY IN CIRRHOTIC RAT LIVERS | Publicación